Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jul 1, 2026
Reporting period
Not applicable
Filed with the SEC
Jul 7, 2026
DirectorTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001493152-26-032231
Filed / recorded
Jul 7, 2026, 12:35 AM UTC
Added to OQRO
Oct 8, 2026, 12:30 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Insight Molecular Diagnostics Inc.
Issuer CIK
1642380
Ticker
IMDX
Reporting person
Andrew Arno
Relationship
Director
Security
Common Stock, no par value
Table
Non-derivative (Table I)
Transaction date
Jul 1, 2026
Transaction code
F
Shares / units
12,100
Price per share
$5.69
Acquired / disposed
Disposed (D)
Shares owned after
156,785
Ownership form
Direct
Amendment
No
Footnotes from the filing
The reported disposition reflects shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of 55,000 shares of restricted stock units granted to the reporting person on July 1, 2025. The reporting person did not sell any shares. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.